Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor

Abstract The rapid structural evolution and emergence of novel synthetic cannabinoid receptor agonists (SCRAs) in the recreational market remains a key public health concern. Despite representing one of the largest classes of new psychoactive substances, pharmacological data on new SCRAs is limited,...

Full description

Bibliographic Details
Published in:Pharmacology Research & Perspectives
Main Authors: Monica Patel, Natasha L. Grimsey, Samuel D. Banister, David B. Finlay, Michelle Glass
Format: Article
Language:English
Published: Wiley 2023-12-01
Subjects:
Online Access:https://doi.org/10.1002/prp2.1157